Skip to main content
. 2023 Apr 21;43(6):1289–1301. doi: 10.1007/s10875-023-01472-0

Table 1.

Research interest of the GAIN registry

1 Minimal prevalence of immune-dysregulatory diseases
2 Median age of disease onset
3 Median age at diagnosis and diagnostic delay
4 Median survival
5 Detailed description of phenotypic manifestations of the disease, including infections and comorbidities
6 Detailed description of treatment
7 Detailed description of genetic variants
8 Quality of life of patients